Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus
Acta Dermato-Venereologica · 2023
DOI: 10.2340/actadv.v103.4863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Guan-Yi He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; Graduate Institute of Clinical Medicine, College of Med…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Chronic pruritus is an unpleasant sensory perception that negatively affects quality of life and is common among patients with type 2 diabetes mellitus. Current antipruritic therapies are insufficiently effective. Thus, the mediation of diabetic pruritus by histamine-independent pathways is likely. The aim of this study was to identify possible mediators responsible for diabetic pruritus. A total of 87 patients with type 2 diabetes mellitus were analysed, of whom 59 had pruritus and 28 did not. The 2 groups were assessed for baseline demographics, serum biochemistry parameters, cytokines, and chemokines. This study also investigated the associations of these factors with the severity of itching. Neither haemoglobin A1c nor serum creatinine levels were correlated with severity of itching. Significantly higher levels of interleukin-4 (p = 0.004), interleukin-13 (p = 0.006), granulocyte-macrophage colony-stimulating factor (p < 0.001) and C-X-C motif chemokine ligand 10 (p = 0.028) were observed in the patients with pruritus than in those without pruritus. Moreover, the levels of these mediators were positively correlated with the severity of itching. Thus, novel antipruritic drugs can be developed to target these molecules. This is the first study to compare inflammatory mediators comprehensively in patients with diabetes mellitus with pruritus vs those without pruritus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei City, Taiwan; Department of…
- 4School of Medicine, College of Medicine, China Medical University, Taichung City, Taiwan; Department of Emergency Medicine, China Medical University Hospital, Taichung City, Taiwan; Department of Public Health, China M…
- Subdivision of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
- Department of General Medicine, National Taiwan University Cancer Center, Taipei City, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei City, Taiwan.
- Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan.
Zitieren
APA
He, G. Y., Hsu, T. Y., Chen, C. W., Nien, F. J., Chen, H. Y., Chu, C. Y., & Wang, L. F. (2023). Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.4863
Vancouver
He GY, Hsu TY, Chen CW, Nien FJ, Chen HY, Chu CY, et al. Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.4863
BibTeX
@article{He2023,
author = {He, Guan-Yi and Hsu, Tai-Yi and Chen, Ching-Wen and Nien, Feng-Jung and Chen, Huan-Yuan and Chu, Chia-Yu and Wang, Li-Fang},
title = {Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus},
journal = {Acta Dermato-Venereologica},
year = {2023},
doi = {10.2340/actadv.v103.4863}
}
EUVIMED